Refractory pyoderma gangrenosum treated with infliximab in an infant.
Clin Exp Dermatol
; 39(3): 336-9, 2014 Apr.
Article
en En
| MEDLINE
| ID: mdl-24635074
We report the case of an 11-month-old boy with severe recalcitrant pyoderma gangrenosum refractory to prednisone, dapsone and ciclosporin. Treatment with infliximab was well tolerated, and resulted in an excellent clinical response that has been sustained for 15 months. The characteristics of this condition in children and the use of infliximab in infants are both reviewed.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Antiinflamatorios no Esteroideos
/
Piodermia Gangrenosa
/
Fármacos Dermatológicos
/
Anticuerpos Monoclonales
Límite:
Humans
/
Infant
/
Male
Idioma:
En
Revista:
Clin Exp Dermatol
Año:
2014
Tipo del documento:
Article
País de afiliación:
España
Pais de publicación:
Reino Unido